What the results of Wegovy’s longest clinical trial yet show about ...
WEBMay 13, 2024 · The results showed that the 10% average weight loss for people using Wegovy was sustained for up to 208 weeks, or four years. Patients stayed on the medicine while they sustained the weight...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ …
WEBAug 25, 2023 · The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 …
WEBMay 22, 2024 · A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four years. The medication shows significant cardiovascular benefits and appears to reduce the risk of …
FDA Approves First Treatment to Reduce Risk of Serious Heart …
WEB“Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or...
FDA Approves New Drug Treatment for Chronic Weight …
WEBFDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Wegovy Moves Beyond Weight Loss - The New York Times
WEBMar 11, 2024 · Wegovy, the blockbuster weight loss drug, is now approved for a new use: reducing the risk of heart attacks, strokes and cardiovascular-related death in adults who have heart disease and are...
Trial confirms heart benefits of Wegovy, but is weight loss ... - CNN
WEBNov 11, 2023 · Results from a landmark clinical trial this summer suggested, for the first time, that a medication given for weight loss alone could reduce the risk of heart attack, stroke or heart-related...
Where Ozempic, Wegovy and New Weight Loss Drugs Came …
WEBAug 17, 2023 · And results from a clinical trial reported last week indicate that Wegovy can do more than help people lose weight — it also can protect against cardiac complications, like heart attacks and...
Weight-loss drug Wegovy can be marketed for heart benefits …
WEBMar 8, 2024 · The US Food and Drug Administration on Friday approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label, making it the first weight-loss drug to also...
Novo's Wegovy shows heart benefit alongside weight loss in trial
WEBAug 8, 2023 · Wegovy maker Novo Nordisk said on Tuesday a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit, boosting the Danish company's hopes of moving...
- Some results have been removed